摘要
目的探讨普鲁卡因治疗晚期肺癌癌性疼痛伴咯血的疗效。方法对11例晚期肺癌出现癌性疼痛伴咯血患者,在常规止血、止痛治疗的基础上,加普鲁卡因静脉滴注,分别观察对癌性疼痛和咯血的疗效。结果常规治疗癌性疼痛有效率为45.4%;加普鲁卡因治疗后,有效率提高到90.9%,两者之间有显著差异(P<0.05);常规治疗咯血有效率为36.3%;加普鲁卡因治疗后,有效率提高到81.8%,两者之间有显著差异(P<0.05)。结论在常规止血止痛方法基础上,配合使用普鲁卡因,将显著提高对晚期肺癌癌性疼痛和咯血的临床疗效。
Objective To investigate the therapeutic effects of procaine on advanced lung cancer pain complicated with hemoptysis. Methods Eleven patients with advanced lung cancer pain complicated with hemoptysis received the intravenous injection with procaine bases on the routine hemostatic and analgesic therapy. The curative effects on cancer pain and hemoptysis were observed. Results The effective rate of routine treatment on cancer pain was 45.4%. After the using of procaine, the effective rate increased to 90.9%. The differences were significant （P 〈 0.05）. The effective rate of routine treatment on hemoptysis rate was 36.3%. After the using of procaine, the effective rate increased to 81.8%, and there was significant differences between them （P 〈 0.05 ）. Conclusion Based on the conventional hemostatic and analgesic therapy, the additional use of procaine can significantly improve the clinical curative effects on cancer pain and hemoptysis in patients with advanced lung cancer.
出处
《西南国防医药》
CAS
2014年第3期283-285,共3页
Medical Journal of National Defending Forces in Southwest China
